Log in to save to my catalogue

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6364999

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In a multicenter trial in 566 patients with critical illness who had delirium, the use of haloperidol or ziprasidone, as compared with placebo, had no significant effect on the duration of delirium or coma. Side effects and extrapyramidal disorders occurred at similar rates in all groups.

Alternative Titles

Full title

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6364999

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6364999

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1808217

How to access this item